The DEA’s medical marijuana registration portal opened on April 29. By the morning of May 2, nearly 400 businesses had signed up. Operators are racing a June 26 deadline that unlocks a six-month review timeline, the right to keep operating during pendency, and the end of 280E for Schedule III medical cannabis. The federal medical cannabis market just opened for business.
The Drug Enforcement Administration opened its Medical Marijuana Dispensary Registration Portal at 12 p.m. Eastern on April 29. Three days later, nearly 400 businesses had signed up. The portal is the first concrete piece of federal infrastructure built for state-licensed medical cannabis operators in U.S. history, and the industry is treating it that way.
Per Marijuana Herald, the portal had at least 391 sign-ups as of the morning of May 2. The system charges $794 annually, payable nonrefundably via PayPal (DEA says other payment methods are coming). It requires seven sections of disclosure including personal and business information, ownership, state licenses, supplier identification, security infrastructure and criminal history. Applicants are paying just to start the application, with no guarantee of approval.
They are paying anyway, because of what is on the other side.
By the numbers
The DEA medical marijuana portal in its first 72 hours.
391
Sign-ups in the first three days
$794
Annual application fee, nonrefundable
June 26
Deadline to file under the 60-day expedited window
6 mo.
DEA response time guaranteed for early filers
Sources: DEA, Department of Justice, Foley Hoag LLP analysis.
The June 26 deadline is the real story
The portal opened on the heels of the Department of Justice’s April 23 Final Order, which immediately placed cannabis “subject to a state medical marijuana license” in Schedule III of the Controlled Substances Act, alongside FDA-approved cannabis products. The order was published in the Federal Register on April 28. That date matters because it started the clock on a 60-day expedited registration window.
According to analysis from cannabis-focused law firm Foley Hoag LLP, applications filed within that window (i.e., by approximately June 26, 2026) are guaranteed a six-month DEA response timeline. Critically, operators in the queue are allowed to continue operations during the pendency of their application. Applications filed after the deadline have no such guarantee.
That structure is what’s driving the rush. 391 sign-ups in 72 hours is not excessive. It is the cannabis industry doing math.
280E is the payoff
The single biggest reason an operator would pay $794 to start an application is the end of Section 280E.
For more than a decade, 280E has been the federal tax provision crushing the U.S. cannabis industry. Because the code disallows business deductions and credits for any company “trafficking” in Schedule I or II controlled substances, state-licensed cannabis operators have effectively been taxed on gross revenue rather than net income. Effective tax rates of 50% to 70% have been routine. Multistate operators have collectively paid hundreds of millions in 280E tax that any other industry would have deducted.
Schedule III ends that. On April 23, the same day DOJ issued the rescheduling order, the U.S. Department of the Treasury and the IRS announced they would issue guidance on the federal tax consequences. Both agencies acknowledged the rescheduling will have “significant positive tax consequences” for state-licensed medical cannabis operators, because 280E no longer applies to Schedule III substances.
For an operator paying $794 annually for a federal registration that ends 280E exposure on the medical side of the business, the math is not close. It is the highest-ROI line item the industry has seen in a decade.
A novel federal-state arrangement
The framework underlying the registration process is itself a departure from how the DEA usually works. Per Foley Hoag, the DOJ’s Final Order treats a state medical marijuana license as “conclusive evidence” that the applicant is authorized under state law for the activity for which DEA registration is sought. In other words, DEA is not re-litigating state-level licensing. It is piggybacking on it.
The legal community is calling this a “cooperative federalism” approach. State regulators do the front-end vetting. DEA does the federal layer on top. For the first time in the regulated cannabis era, federal and state cannabis frameworks are designed to work in tandem rather than ignore each other.
The buyback theater
For cultivators and manufacturers, the framework gets weirder. The 1971 United Nations Convention on Psychotropic Substances requires that a single government agency serve as “the exclusive purchaser of cannabis production.” To satisfy that obligation, the rescheduling order has the DEA effectively buy and immediately sell back every registered cultivator’s crops at the same nominal price, plus an administrative fee.
As reported by Marijuana Moment, the order specifies: “Registered manufacturers must store crops in a facility to which DEA maintains access until that transaction is complete, and each manufacturer registration must specify the areas in which cultivation is permitted.” Manufacturers set a nominal price. DEA buys at that price. DEA sells back at the same price plus the administrative fee. The crop never moves.
It is regulatory theater. It is also the price of treaty compliance. Cultivators planning to register should expect this paperwork loop to be a permanent feature of the federal medical cannabis system.
What comes next
The current Schedule III move only covers state-licensed medical cannabis and FDA-approved products. Adult-use cannabis remains Schedule I.
That changes (or doesn’t) starting June 29, when the DEA holds the formal evidentiary hearing on whether to reschedule all cannabis. The hearing was reinstated under the April 23 order, replacing the previously withdrawn process from the prior administration. White House Press Secretary Karoline Leavitt has said the Trump administration is moving forward with rescheduling because cannabis reform is “overwhelmingly popular” and will help reduce illegal cannabis flows.
If the June 29 hearing leads to full rescheduling, the registration system that just opened for medical operators could expand to cover the entire industry. The 280E benefits flow to adult-use operators, too. The federal/state cooperative framework becomes the template for U.S. cannabis regulation, full stop.
If the hearing produces something less than full rescheduling, the medical-only framework that opened on April 29 becomes the entirety of federal cannabis legitimacy for the foreseeable future. Adult-use stays where it is.
Either way, by the morning of May 2, nearly 400 businesses had decided to find out from the inside.
